Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth

Zhaowen Zhu, Jörg Kleeff, Helmut Friess, Li Wang, Arthur Zimmermann, Yosef Yarden, Markus W. Büchler, Murray Korc

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Epiregulin belongs to the epidermal growth factor (EGF) family of polypeptides. Previous studies have underscored the important role of the EGF family of ligands and receptors in the pathology of pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). It is not known, however, whether epiregulin may also have a role in these diseases. Therefore, in the present study we investigated the expression and function of epiregulin in five pancreatic cancer cell lines and in PDAC and CP tissue samples. Epiregulin mRNA was present at high (MIA-PaCa-2 cells) or moderate levels (ASPC-1, CAPAN-1, and T3M4) in most cells, but was below detection levels in PANC-1 cells. All the cell lines exhibited a dose-dependent increase in growth in response to recombinant human epiregulin. Epiregulin mRNA levels were increased 2.1-fold in PDAC samples (P <0.01) and 1.7-fold in CP samples (P <0.01), when compared with the normal controls. There was no correlation between epiregulin mRNA levels and tumor stage or grade. By in situ hybridization, a moderate to intense epiregulin mRNA signal was present in most pancreatic cancer cells in PDAC. In contrast, only a weak (normal pancreas) to moderate (CP) signals were present in the ductal and acinar cells in CP. These findings suggest that epiregulin may contribute to the pathobiology of PDAC, and may also have a role in CP. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)1019-1024
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume273
Issue number3
DOIs
StatePublished - Jul 14 2000
Externally publishedYes

Fingerprint

Cell growth
Pancreatic Neoplasms
Chronic Pancreatitis
Growth
Adenocarcinoma
Messenger RNA
Cells
Epidermal Growth Factor
Epiregulin
Cell Line
Acinar Cells
Pathology
In Situ Hybridization
Tumors
Pancreas
Tissue
Ligands
Peptides

Keywords

  • Chronic pancreatitis
  • Epidermal growth factor
  • Epiregulin
  • Pancreatic ductal adenocarcinoma

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. / Zhu, Zhaowen; Kleeff, Jörg; Friess, Helmut; Wang, Li; Zimmermann, Arthur; Yarden, Yosef; Büchler, Markus W.; Korc, Murray.

In: Biochemical and Biophysical Research Communications, Vol. 273, No. 3, 14.07.2000, p. 1019-1024.

Research output: Contribution to journalArticle

Zhu, Z, Kleeff, J, Friess, H, Wang, L, Zimmermann, A, Yarden, Y, Büchler, MW & Korc, M 2000, 'Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth', Biochemical and Biophysical Research Communications, vol. 273, no. 3, pp. 1019-1024. https://doi.org/10.1006/bbrc.2000.3033
Zhu, Zhaowen ; Kleeff, Jörg ; Friess, Helmut ; Wang, Li ; Zimmermann, Arthur ; Yarden, Yosef ; Büchler, Markus W. ; Korc, Murray. / Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. In: Biochemical and Biophysical Research Communications. 2000 ; Vol. 273, No. 3. pp. 1019-1024.
@article{37a81fadcd7b490684ad1dd19111fa46,
title = "Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth",
abstract = "Epiregulin belongs to the epidermal growth factor (EGF) family of polypeptides. Previous studies have underscored the important role of the EGF family of ligands and receptors in the pathology of pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). It is not known, however, whether epiregulin may also have a role in these diseases. Therefore, in the present study we investigated the expression and function of epiregulin in five pancreatic cancer cell lines and in PDAC and CP tissue samples. Epiregulin mRNA was present at high (MIA-PaCa-2 cells) or moderate levels (ASPC-1, CAPAN-1, and T3M4) in most cells, but was below detection levels in PANC-1 cells. All the cell lines exhibited a dose-dependent increase in growth in response to recombinant human epiregulin. Epiregulin mRNA levels were increased 2.1-fold in PDAC samples (P <0.01) and 1.7-fold in CP samples (P <0.01), when compared with the normal controls. There was no correlation between epiregulin mRNA levels and tumor stage or grade. By in situ hybridization, a moderate to intense epiregulin mRNA signal was present in most pancreatic cancer cells in PDAC. In contrast, only a weak (normal pancreas) to moderate (CP) signals were present in the ductal and acinar cells in CP. These findings suggest that epiregulin may contribute to the pathobiology of PDAC, and may also have a role in CP. (C) 2000 Academic Press.",
keywords = "Chronic pancreatitis, Epidermal growth factor, Epiregulin, Pancreatic ductal adenocarcinoma",
author = "Zhaowen Zhu and J{\"o}rg Kleeff and Helmut Friess and Li Wang and Arthur Zimmermann and Yosef Yarden and B{\"u}chler, {Markus W.} and Murray Korc",
year = "2000",
month = "7",
day = "14",
doi = "10.1006/bbrc.2000.3033",
language = "English (US)",
volume = "273",
pages = "1019--1024",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth

AU - Zhu, Zhaowen

AU - Kleeff, Jörg

AU - Friess, Helmut

AU - Wang, Li

AU - Zimmermann, Arthur

AU - Yarden, Yosef

AU - Büchler, Markus W.

AU - Korc, Murray

PY - 2000/7/14

Y1 - 2000/7/14

N2 - Epiregulin belongs to the epidermal growth factor (EGF) family of polypeptides. Previous studies have underscored the important role of the EGF family of ligands and receptors in the pathology of pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). It is not known, however, whether epiregulin may also have a role in these diseases. Therefore, in the present study we investigated the expression and function of epiregulin in five pancreatic cancer cell lines and in PDAC and CP tissue samples. Epiregulin mRNA was present at high (MIA-PaCa-2 cells) or moderate levels (ASPC-1, CAPAN-1, and T3M4) in most cells, but was below detection levels in PANC-1 cells. All the cell lines exhibited a dose-dependent increase in growth in response to recombinant human epiregulin. Epiregulin mRNA levels were increased 2.1-fold in PDAC samples (P <0.01) and 1.7-fold in CP samples (P <0.01), when compared with the normal controls. There was no correlation between epiregulin mRNA levels and tumor stage or grade. By in situ hybridization, a moderate to intense epiregulin mRNA signal was present in most pancreatic cancer cells in PDAC. In contrast, only a weak (normal pancreas) to moderate (CP) signals were present in the ductal and acinar cells in CP. These findings suggest that epiregulin may contribute to the pathobiology of PDAC, and may also have a role in CP. (C) 2000 Academic Press.

AB - Epiregulin belongs to the epidermal growth factor (EGF) family of polypeptides. Previous studies have underscored the important role of the EGF family of ligands and receptors in the pathology of pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). It is not known, however, whether epiregulin may also have a role in these diseases. Therefore, in the present study we investigated the expression and function of epiregulin in five pancreatic cancer cell lines and in PDAC and CP tissue samples. Epiregulin mRNA was present at high (MIA-PaCa-2 cells) or moderate levels (ASPC-1, CAPAN-1, and T3M4) in most cells, but was below detection levels in PANC-1 cells. All the cell lines exhibited a dose-dependent increase in growth in response to recombinant human epiregulin. Epiregulin mRNA levels were increased 2.1-fold in PDAC samples (P <0.01) and 1.7-fold in CP samples (P <0.01), when compared with the normal controls. There was no correlation between epiregulin mRNA levels and tumor stage or grade. By in situ hybridization, a moderate to intense epiregulin mRNA signal was present in most pancreatic cancer cells in PDAC. In contrast, only a weak (normal pancreas) to moderate (CP) signals were present in the ductal and acinar cells in CP. These findings suggest that epiregulin may contribute to the pathobiology of PDAC, and may also have a role in CP. (C) 2000 Academic Press.

KW - Chronic pancreatitis

KW - Epidermal growth factor

KW - Epiregulin

KW - Pancreatic ductal adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0034647713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034647713&partnerID=8YFLogxK

U2 - 10.1006/bbrc.2000.3033

DO - 10.1006/bbrc.2000.3033

M3 - Article

C2 - 10891365

AN - SCOPUS:0034647713

VL - 273

SP - 1019

EP - 1024

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -